SAM
TEVA icon

Storebrand Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History

Storebrand Asset Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-712,631
Closed -$8.22M – 842
2021
Q1 		$8.22M Buy
712,631
+535,459
+302% +$6.14M 0.04% 411
2020
Q4 		$1.71M Sell
177,172
-218,199
-55% -$2.09M 0.01% 654
2020
Q3 		$3.56M Buy
395,371
+29,917
+8% +$316K 0.03% 500
2020
Q2 		$4.51M Buy
365,454
+282,017
+338% +$3.19M 0.04% 411
2020
Q1 		$749K Buy
+83,437
New +$855K 0.01% 639

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

Storebrand Asset Management's TEVA Position: Q2 2021 in Review

Storebrand Asset Management sold out of Teva Pharmaceuticals (TEVA) in Q2 2021, closing a stake of 712,631 shares — an estimated $8.22M sold.

Storebrand Asset Management first reported a position in TEVA in Q1 2020 and held it in 5 quarters. The position peaked at $8.22M in Q1 2021. 440 funds tracked by Wall St. Rank hold TEVA as of Q2 2021.

  • Storebrand Asset Management reported no remaining Teva Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • Storebrand Asset Management sold 712,631 Teva Pharmaceuticals shares in Q2 2021, an estimated $8.22M.
  • Storebrand Asset Management first reported a position in Teva Pharmaceuticals in Q1 2020 and held it in 5 quarters.
  • Storebrand Asset Management's Teva Pharmaceuticals position peaked at $8.22M in Q1 2021.
  • 440 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2021.

Based on Storebrand Asset Management's 13F filing for Q2 2021, filed 18 Jun 2026.